Annie Lennon

Glucagon-like peptide-1 (GLP-1) receptor agonists used to treat type 2 diabetes and obesity could help reduce risk of addiction to substances like cannabis, alcohol, and cocaine. The corresponding study was published in The BMJ. “As use of GLP-1 receptor ... See more

One of semaglutide’s inactive ingredients has been linked to changes in gut bacteria and inflammatory markers. The corresponding study was published in The Journal of Controlled Release. "Obesity is a complex, chronic disease with serious health consequen... See more

Researchers have designed a nanomaterial that destroys cancer cells without harming surrounding healthy tissues in cell and animal models. The corresponding study was published in Advanced Functional Materials and may pave the way for new treatment option... See more

Le Comité des médicaments à usage humain (CHMP) de l’Agence européenne des médicaments (EMA) a recommandé l’octroi d’une autorisation de mise sur le marché conditionnelle au sémaglutide (Kayshild, Novo Nordisk) pour les adultes atteints de stéatohépatite ... See more

Low-dose lithium may help slow verbal memory decline– the ability to remember and recall words and sentences– in older adults with mild cognitive impairment (MCI). The corresponding pilot study was published in JAMA Neurology. “In a prior study, we observ... See more